AdAlta
AdAlta - Discovering and Developing Protein Based Therepeutics.
Launch date
Employees
Market cap
€6.8m
Enterprise valuation
€7m (Public information from Sep 2024)
Share price
AUD0.019 1AD.AX
Company register number 120332925
Melbourne Victoria (HQ & founding location)
Financials
Estimates*
| AUD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | <1m | <1m | <1m | 3.2m | - |
| % growth | - | - | - | 38 % | 16 % | 224 % | - |
| EBITDA | - | - | (5.8m) | (5.5m) | (5.9m) | (4.7m) | - |
| % EBITDA margin | - | - | (950 %) | (649 %) | (599 %) | (147 %) | - |
| Profit | - | - | (6.0m) | (5.6m) | (6.1m) | (4.9m) | - |
| % profit margin | - | - | (975 %) | (664 %) | (614 %) | (152 %) | - |
| EV / revenue | - | - | 20.7x | 31.3x | 12.5x | 2.5x | - |
| EV / EBITDA | - | - | -2.2x | -4.8x | -2.1x | -1.7x | - |
| R&D budget | - | - | - | 6.2m | 4.1m | 3.6m | - |
| R&D % of revenue | - | - | - | 735 % | 418 % | 114 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$3.0m | Series A | ||
AUD50.0k | Grant | ||
| N/A | N/A | IPO | |
AUD1.0m | Grant | ||
| N/A | AUD8.1m | Private Placement VC | |
* | N/A | AUD1.9m | Post IPO Equity |
| Total Funding | €8.1m | ||
Recent News about AdAlta
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.